💊 Drugmakers Expand U.S. Presence Amid Tariff Threat

Tariff fears drive pharma giants to shift supply chains closer to home.

Global drugmakers are fast-tracking plans to expand U.S. manufacturing facilities in response to looming 100% tariffs on branded drugs. The new trade policy aims to force companies to localize production, though critics warn it could drive up costs.
European and Asian pharmaceutical shares dropped on the news, with Indian exporters hit hardest. Companies are now weighing whether exemptions for local investments will protect revenues.
Analysts say the shift could reshape global supply chains, raising questions about drug pricing, availability, and competition in the coming years.